Updates in Heart Failure 2026
14-15 December 2026
Stockholm, Sweden
DAY 1 – 14 December 2026
12:00-13:00
Lunch
- 13:00-13:05 | Welcome and Introduction
Gianluigi Savarese, Sweden
Session 1: HFrEF in 2026: Guidelines & beyond?
Chairs: Michael Melin (Sweden), Gianluigi Savarese (Sweden)
13:05–14:25
- 13:05–13:15 | 2026 ESC/HFA Guidelines on HF
Marianna Adamo, Italy - 13:15–13:25 | Four Pillars in Real-World Practice
Alexandre Mebazaa, France - 13:25–13:35 | Digitoxin/Digoxin after DIGIT-HF/DECISION
Peter van der Meer, The Netherlands - 13:35–13:45 | Vericiguat after VICTOR
Javed Butler, United States - 13:45–13:55 | HFimpEF: Recovery or Remission or..?
Biykem Bozkurt, United States - 13:55–14:25 | Expert Exchange
Session 2: Cardiorenal Syndrome 2026
Chairs: Biykem Bozkurt (United States), Jonas Spaak (Sweden)
14:25–15:40
- 14:25–14:30 | Clinical Case
Francesca Musella, Italy - 14:30–14:40 | Beyond eGFR
Cristina Gavina, Portugal - 14:40–14:50 | Treating CKD & Heart Failure
Gerasimos Filippatos, Greece - 14:50–15:00 | Hyperkalaemia
Felix Lindberg, Sweden - 15:00–15:10 | Potassium Binders
Javed Butler, United States - 15:10–15:40 | Discussion
15:40–16:10
Coffee Break
Session 3: HFpEF in 2026: One Syndrome, Many Phenotypes
Chairs: Lars H. Lund (Sweden), Giuseppe Rosano (United Kingdom)
16:10–17:40
- 16:10–16:20 | Finding HFpEF Earlier
Cristina Gavina, Portugal - 16:20–16:30 | Foundational Therapy in HFpEF
Riccardo Inciardi, Italy - 16:30–16:40 | Obesity-Related HFpEF
Gianluigi Savarese, Sweden - 16:40–16:50 | AF-Dominant HFpEF
Frieder Braunschweig, Sweden - 16:50–17:00 | Hypertensive HFpEF
Stefano Masi, Italy - 17:00–17:10 | HFpEF and Pulmonary Hypertension
Stephan Rosenkranz, Germany - 17:10–17:40 | Debate
Session 4: Emerging Therapies in Heart Failure
Chairs: Carin Corovic Cabrera (Sweden), Francesco Cosentino (Sweden)
17:40–18:30
- 17:40–17:50 | RNA and Gene Editing Therapies
Peter van der Meer, The Netherlands - 17:50–18:00 | Inflammation and Fibrosis
Davide Stolfo, Italy / Sweden - 18:00–18:10 | Treating MASLD to Prevent Heart Failure: Are We Entering a New Era?
Nicolas Girerd, France - 18:10–18:30 | Discussion
- 18:30–18:35 | Wrap-Up
- 18:35–19:15 | Networking & Mingle Reception
DAY 2 – 15 December 2026
- 08:30–08:35 | Welcome
- 08:35–08:55 | State-of-the-Art Lecture
Iron Deficiency in Heart Failure: From HFrEF to HFpEF—What Comes Next?
John Cleland, United Kingdom | Chair: Gianluigi Savarese (Sweden)
Session 5: Residual Risk in Heart Failure
08:55–10:10
Chairs: Lars H. Lund (Sweden), Luciano Potena (Italy)
- 08:55–09:00 | Clinical Case
Benedikt Beer, Sweden / Germany - 09:00–09:10 | ICD Therapy in 2026
Biykem Bozkurt, United States - 09:10–09:20 | CRT and Conduction System Pacing
Klaus Witte, United Kingdom - 09:20–09:30 | Advanced HF: Referral Timing
Oscar Braun, Sweden - 09:30–09:40 | Treating Advanced HF
Benedikt Schrage, Germany - 09:40–10:10 | Discussion
10:10–10:45
Coffee Break
Session 6: Valvular Heart Disease in Heart Failure
10:45–12:00
Chairs: Robin Hofmann (Sweden), Mitja Lainscak (Slovenia)
- 10:45–10:50 | Clinical Case
Christian Basile, Italy / Sweden - 10:50–11:00 | Mitral Regurgitation in HF
Marco Metra, Italy - 11:00–11:10 | Tricuspid Regurgitation in HF
Marianna Adamo, Italy - 11:10–11:20 | Aortic Stenosis and HF
Bahira Shahim, Sweden - 11:20–11:30 | Heart Team Approach
Andreas Rück, Sweden - 11:30–12:00 | Discussion
12:00–13:00
Lunch
Session 7: Personalising Congestion Management in Heart Failure
13:00–13:50
Chairs: Luca Monzo (France), Gianluigi Savarese (Sweden)
- 13:00–13:10 | Congestion in 2026: current treatment algorithms
Jan Biegus, Poland - 13:10–13:20 | Defining phenotypes of congestion in heart failure: implications for treatment
Daan Ceelen, The Netherlands - 13:20–13:30 | Cardiorenal syndrome and diuretic resistance in heart failure: diagnosis and therapeutic approaches
Julio Nuñez, Spain - 13:30–13:35 | The BIOTOOL-CHF project
Luciano Potena, Italy - 13:35–13:50 | Discussion
- 13:50–14:10 | State-of-the-Art Lecture: Heart Failure, Cancer and Frailty: Shared Pathways, Shared Challenges
Stefan D. Anker, Germany | Chair: Ovidiu Chioncel (Romania)
14:10–14:30
Coffee Break
Session 8: Cardiomyopathies in 2026
14:30–15:30
Chairs: Per Eldhagen (Sweden), Mitja Lainscak (Slovenia), Raffaele Scorza (Sweden)
- 14:30–14:40 | Cardiac Amyloidosis
Felix Lindberg, Sweden - 14:40–14:50 | ATTR-CM Therapies
Daniela Tomasoni, Italy / Sweden - 14:50–15:00 | Hypertrophic Cardiomyopathy
Iacopo Olivotto, Italy - 15:00–15:10 | Clinical Case – Identifying Diagnostic Pathways
Antonio Cannata, United Kingdom - 15:10–15:30 | Discussion
Session 9: Delivering Better Heart Failure Care in 2026
15:30–16:20
Chairs: Ovidiu Chioncel (Romania), Michael Melin (Sweden), Luca Monzo (France)
- 15:30–15:40 | Telemonitoring and Remote Management
Nicolas Girerd, France - 15:40–15:50 | Polypharmacy, Adherence and Persistence
Giuseppe Rosano, United Kingdom - 15:50–16:00 | Multidisciplinary HF Care and Transitions of Care
Camilla Hage, Sweden - 16:00–16:20 | Expert Panel Discussion
- 16:20–16:45 | Closing Remarks